|
BAZ1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.135970E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.152100E-02 |
| Normal-vs-Stage2 |
4.279800E-01 |
| Normal-vs-Stage3 |
4.424200E-03 |
| Normal-vs-Stage4 |
3.338900E-03 |
| Stage1-vs-Stage2 |
2.749200E-01 |
| Stage1-vs-Stage3 |
3.049200E-01 |
| Stage1-vs-Stage4 |
2.876000E-01 |
| Stage2-vs-Stage3 |
1.061350E-01 |
| Stage2-vs-Stage4 |
1.028980E-01 |
| Stage3-vs-Stage4 |
7.999800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.397650E-02 |
| Normal-vs-AfricanAmerican |
5.051000E-01 |
| Normal-vs-Asian |
2.422100E-02 |
| Caucasian-vs-AfricanAmerican |
3.082200E-01 |
| Caucasian-vs-Asian |
7.679400E-01 |
| AfricanAmerican-vs-Asian |
2.664400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.395800E-03 |
| Normal-vs-Female |
2.330100E-02 |
| Male-vs-Female |
3.096000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.463800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.835900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.777500E-03 |
| Normal-vs-Age(81-100Yrs) |
3.221700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.046200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.080200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.082000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.679000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.048400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.915600E-02 |
| Classical-VS-Follicular |
7.559700E-03 |
| Classical-VS-Other |
1.512620E-01 |
| Classical-VS-Normal |
1.185800E-01 |
| Tall-VS-Follicular |
8.677200E-01 |
| Tall-VS-Other |
6.637800E-01 |
| Tall-VS-Normal |
4.315400E-03 |
| Follicular-VS-Other |
6.376400E-01 |
| Follicular-VS-Normal |
2.281200E-03 |
| Other-VS-Normal |
4.132400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.450090E-02 |
| Normal-vs-N1 |
2.237900E-03 |
| N0-vs-N1 |
2.559800E-01 |
|
|
